作者
James Yarmolinsky, Kaitlin H Wade, Rebecca C Richmond, Ryan J Langdon, Caroline J Bull, Kate M Tilling, Caroline L Relton, Sarah J Lewis, George Davey Smith, Richard M Martin
发表日期
2018/9/1
来源
Cancer Epidemiology, Biomarkers & Prevention
卷号
27
期号
9
页码范围
995-1010
出版商
American Association for Cancer Research
简介
Observational epidemiologic studies are prone to confounding, measurement error, and reverse causation, undermining robust causal inference. Mendelian randomization (MR) uses genetic variants to proxy modifiable exposures to generate more reliable estimates of the causal effects of these exposures on diseases and their outcomes. MR has seen widespread adoption within cardio-metabolic epidemiology, but also holds much promise for identifying possible interventions for cancer prevention and treatment. However, some methodologic challenges in the implementation of MR are particularly pertinent when applying this method to cancer etiology and prognosis, including reverse causation arising from disease latency and selection bias in studies of cancer progression. These issues must be carefully considered to ensure appropriate design, analysis, and interpretation of such studies. In this review, we …
引用总数
20182019202020212022202320245151915262533
学术搜索中的文章
J Yarmolinsky, KH Wade, RC Richmond, RJ Langdon… - Cancer Epidemiology, Biomarkers & Prevention, 2018